Volume loss of the medial temporal lobe structures in subjective memory impairment

Dementia and Geriatric Cognitive Disorders

Volumn 29, Issue 1, 2010, Pages 75-81

  Striepens, Nadine ^a   Scheef, Lukas ^a   Wind, Andrea ^a   Popp, Julius ^a   Spottke, Annika ^a   Cooper Mahkorn, Déirdre ^a   Suliman, Husam ^a,b   Wagner, Michael ^a   Schild, Hans H ^a   Jessen, Frank ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Alzheimer's disease; Amygdala; Entorhinal cortex; Hippocampus; Subjective memory impairment

Indexed keywords

ADULT; AGED; AMYGDALOID NUCLEUS; ANATOMICAL VARIATION; ARTICLE; BRAIN SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; ENTORHINAL CORTEX; FEMALE; HIPPOCAMPUS; HUMAN; IMAGE ANALYSIS; MALE; MEMORY DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; STRUCTURE ANALYSIS; SUBJECTIVE MEMORY IMPAIRMENT; TISSUE STRUCTURE;

AGED; AMYGDALA; APOLIPOPROTEINS E; BRAIN; EDUCATION; ENTORHINAL CORTEX; FEMALE; FUNCTIONAL LATERALITY; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEMORY DISORDERS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; TEMPORAL LOBE;

EID: 75149129630     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000264630     Document Type: Article

References (41)

1. Cummings JL, Cole G: Alzheimer disease. J Am Med Assoc 2002; 287: 2335-2338.
2. Morris JH, Hof PR: Life and death of neurons in the aging brain. Science 1997; 78: 412-419.
3. Braak H, Braak E: Neuropathological staging of Alzheimer-related changes. Acta Neuropathol (Berl) 1991; 82: 239-259.
4. Frisoni GB, Beltramello A, Weiss C, et al: Linear measures of atrophy in mild Alzheimer disease. Am J Neuroradiol 1996; 17: 913-923.
5. Laakso MP, Soininen H, Partanen K, et al: Volumes of hippocampus, amygdala and frontal lobes in the MRI-based diagnosis of early Alzheimer's disease: correlation with memory functions. J Neural Transm Park Dis Dement 1995; 9: 73-86.
6. Gauthier S, Poerier J: Current and future management of Alzheimer's disease. Alzheimer Dementia 2008; 4:S48-S50.
7. Fillit H: Drug discovery and the prevention of Alzheimer's disease. Alzheimers Dement 2008; 4:S26-S28.
8. Petersen RC, Doody R, Kurz A, et al: Current concepts in mild cognitive impairment. Arch Neurol 2001; 58: 1985-1992.
9. Winblad B, Palmer K, Kivipelto M, et al: Mild cognitive impairment-beyond controversies towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004; 256: 240-246.
10. Petersen RC: Mild cognitive impairment as a diagnostic entity. J Intern Med 2004; 256: 183-184.
11. Barnes LL, Schneider JA, Boyle PA, Bienias JL, Bennett DA: Memory complaints are related to Alzheimer disease pathology in older persons. Neurology 2006; 67: 1581-1585.
12. Morris JC, Price AL: Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disese. J Mol Neurosci 2001; 17: 101-118.
13. Hua X, Leow AD, Parikshak N, et al: Tensorbased morphometry as a neuroimaging biomarker for Alzheimer's disease: an MRI study of 676 AD, MCI and normal subjects. Neuroimage 2008; 43: 458-469.
14. Seo SW, Im K, Lee JM, et al: Cortical thickness in single-versus multiple-domain amnestic mild cognitive impairment. Neuroimage 2007; 36: 289-297.
15. Whitwell JL; Shiung MM, Przybelski SA, et al: MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment. Neurology 2008; 70: 512-520.
16. Dickerson BC, Goncharova I, Sullican MP, et al: MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer's disease. Neurobiol Aging 2001; 22: 747-754.
17. Visser PJ, Verhey FR, Hofman PA, et al: Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment. J Neurol Neurosurg Psychiatry 2002; 72: 491-497.
18. Delacourte A, David JP, Sergeant N, et al: The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease. Neurology 1999; 52: 1158-1165.
19. Gauthier S, Juby A, Morelli L, et al: A large, naturalistic, community-based study of rivastigmine in mild-to-moderate AD: the EXTEND study. Curr Med Res Opin 2006; 22: 2251-2265.
20. Reisberg B, Gauthier S: Current evidence for subjective cognitive impairment (SCI) as the pre-mild cognitive impairment (MCI) stage of subsequently manifest Alzheimer's disease. Int Psychogeriatr 2008; 20: 1-16.
21. Jonker C, Geerlings MI, Schmand B: Are memory complaints predictive for dementia? A review of clinical and populationbased studies. Int J Geriatr Psychiatry 2000; 15: 983-991.
22. Jessen F, Wiese B, Bachmann C, et al: Prediction of dementia by subjective memory impairment- effects of severity and temporal association with cognitive impairment. Arch Gen Psychiatry 2009, in press.
23. Tepest R, Wang L, Csernansky JG, et al: Hippocampal surface analysis in subjective memory impairment, mild cognitive impairment and Alzheimer's dementia. Dement Geriatr Cogn Disord 2008; 26: 323-329.
24. Chao S, Robert JS, Mareau TM, et al: Health behaviour changes after genetic risk assessment for Alzheimer disease: the REVEAL Study. Alzheimer Dis Assoc Disord 2008; 22: 94-97.
25. Saykin AJ, Wishart HA, Rabin LA, et al: Older adults with cognitive complaints show brain atrophy similar to that of amnestic MCI. Neurology 2006; 67: 834-842.
26. Van Norden AG, Fick WF, de Laat KF, et al: Subjective cognitive failures and hippocampal volume in elderly with white matter lesions. Neurology 2008; 71: 1152-1159.
27. Jessen F, Feyen L, Freymann K, et al: Volume reduction of the entorhinal cortex in subjective memory impairment. Neurobiol Aging 2006; 27: 1751-1756.
28. Carr DB, Gray S, Baty J, Morris JC: The value of informant versus individual's complaints of memory impairment in early dementia. Neurology 2000; 55: 1724-1726.
29. Morris JC, Heyman A, Mohs RC, et al: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989; 39: 1159-1165.
30. Insausti R, Juottonen K, Soininen H, et al: MR volumetric analysis of the human entorhinal, perirhinal, and temporopolar cortices. AJNR 1998; 19: 659-671.
31. Goncharova Il, Dickerson BC, Stoub TR, et al: MRI of human entorhinal cortex: a reliable protocol for volumetric measurement. Neurobiol Aging 2001; 22: 737-745.
32. Pruessner JC, Li LM, Series W, et al: Volumetry of hippocampus and amygdala with high-resolution MRI and three-dimensional analysis software: minimizing the discrepancies between laboratories. Cereb Cortex 2000; 10: 433-442.
33. Killiany RJ, Gomez-Isla T, Moss M, et al: Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease. Ann Neurol 2000; 47: 420-439.
34. Stewart MD, Dufouil C, Godin O, et al: Neuroimaging correlates of subjective memory deficits in a community population. Neurology 2008; 70: 1601-1607.
35. Rentz DM, Huh TJ, Faust RR, et al: Use of IQ-adjusted norms to predict progressive cognitive decline in highly intelligent older individuals. Neuropsychology 2004; 18: 38-49.
36. Horinek D, Varjassyova A, Hort J: Magnetic resonance analysis of amygdalar volume in Alzheimer's disease. Curr Opin Psychiatry 2007; 20: 272-277.
37. Teipel SJ, Pruessner JC, Faltraco F, et al: Comprehensive dissection of the medial temporal lobe in AD: measurement of hippocampus, amygdala, entorhinal, perirhinal and parahippocampal coritces using MRI. J Neurol 2006; 253: 794-800.
38. Bottino CM, Castro CC, Gomes RL, et al: Volumetric MRI measurements can differentiate Alzheimer's disease, mild cognitive impairment, and normal aging. Int Psychogeriatr 2002; 14: 59-72.
39. Petersen RC, Parisi JE, Dickson DW, et al: Neuropathologic features of amnestic mild cognitive impairment. Arch Neurol 2006; 63: 665-672.
40. den Heijer T, Geerlings MI, Hoebeek FE, et al: Use of hippocampal and amygdalar volumes on magnetic resonance imaging to predict dementia in cognitively intact lederly people. Arch Gen Psychiatry 2006; 63: 5-62.
41. Jungwirth S, Fischer P, Weissgram S, et al: Subjective memory complaints and objective memory impairment in the Vienna-Transdanube aging community. J Am Geriatr Soc 2004; 52: 263-268.